학술논문
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan
Document Type
Article
Source
In Contemporary Clinical Trials Communications December 2020 20
Subject
Language
ISSN
2451-8654